Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Liabilities and Shareholders Equity: 2009-2011

Historic Liabilities and Shareholders Equity for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $430.5 million.

  • Lexicon Pharmaceuticals' Liabilities and Shareholders Equity rose 21.42% to $357.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $1.6 billion, marking a year-over-year increase of 19.02%. This contributed to the annual value of $430.5 million for FY2011, which is 17.34% up from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Liabilities and Shareholders Equity of $430.5 million as of FY2011, which was up 17.34% from $366.9 million recorded in FY2010.
  • In the past 5 years, Lexicon Pharmaceuticals' Liabilities and Shareholders Equity registered a high of $430.5 million during FY2011, and its lowest value of $257.8 million during FY2009.
  • In the last 3 years, Lexicon Pharmaceuticals' Liabilities and Shareholders Equity had a median value of $366.9 million in 2010 and averaged $351.7 million.
  • Data for Lexicon Pharmaceuticals' Liabilities and Shareholders Equity shows a peak YoY spiked of 42.33% (in 2010) over the last 5 years.
  • Lexicon Pharmaceuticals' Liabilities and Shareholders Equity (Yearly) stood at $257.8 million in 2009, then surged by 42.33% to $366.9 million in 2010, then grew by 17.34% to $430.5 million in 2011.